1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Drug Delivery Insight 15 SEPTEMBER 2014

Drug Delivery Insight 15 SEPTEMBER 2014

  • September 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Teva Victory Over AstraZeneca Overshadowed By Fierce Respiratory Competition
Industry Brief - Clearside Closes Series B Funding
Industry Brief - Pinnacle/Orphan Canada Collaborate To Support Supply Of PDT With Photofrin
Industry Brief - Pfizer Signs Exclusive UK Distribution Deal For Ultibro/Seebri Breezhaler
Industry Brief - Knight Therapeutics Acquires Orphan Canada
Industry Brief - Omron Acquires Brazil-Based Nebulisers Manufacturer
Industry Brief - AMW Secures Funding For Drug-Delivery Systems Development
Industry Trend Analysis - Spiriva Respimat Inhaler Indications Expand With Untapped Asthma Market Potential
Industry Brief - Ozurdex Marketing Authorisation Extended
Industry Brief - Cedartolen Cedar Pollen Japanese Launch Set For October
Industry Brief - Oncozene/Embozene Receive Clearance For Hepatoma Indication
Industry Brief - Iluvien Receives Swedish Approval For DMO
Industry Brief - DuoResp Spiromax Now Available In UK For Asthma/COPD
Industry Brief - Medtronic Introduces Enhanced Enlite Glucose Sensor In Canada
Industry Brief - Bydureon Diabetes II Pen Available In US Pharmacies
Industry Brief - CivaSheet Brachytherapy Device Granted US Approval
Industry Brief - MHRA Approves Voke Nicotine Inhaler
Industry Brief - Flowonix Seeks FDA Approval For Prometra PMA Supplements
Industry Trend Analysis - Kamada's Failed Trial Not The End Of Inhaled AAT Therapy
Industry Brief - Initial Patient Enrolled In BioFreedom US Trial
Industry Brief - First Patient Enrolled in ThermoDox Phase III HCC Study
Industry Brief - Phase IIa Study Of NeuroDerm's Liquid Levodopa/Carbidopa For PD Commences
Industry Trend Analysis - SGX301 Has Potential To Send Soligenix To Top Of CTCL Market
Industry Brief - Mersana Secures Fleximer ADC Technology US Patents
Industry Brief - Egalet Secures US Patents Covering Guardian Technology/Product Candidates
Industry Brief - Mallinckrodt's MNK-155 Shows Efficacy In Phase III Acute Pain Trial
Industry Brief - Prosonix' Technology Targets Dual/Triple FDC Respiratory Therapies
Industry Brief - Marina Secures Worldwide Patent Protection For Nucleic Acid Delivery Platform

Table Of Contents

Drug Delivery Insight 15 SEPTEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.